Edition:
United States

Roxanne Liu

China's Sinovac vaccine is safe, Brazil institute says

Oct 20 2020

BEIJING/SAO PAULO An experimental coronavirus vaccine developed by China's Sinovac Biotech appeared to be safe in a late-stage clinical trial in Brazil, preliminary results showed on Monday.

Exclusive: 90% of China's Sinovac employees, families took coronavirus vaccine, says CEO

Sep 06 2020

BEIJING About 90% of Sinovac Biotech Ltd employees and their families have taken an experimental coronavirus vaccine developed by the Chinese firm under the country's emergency use program, its chief executive said on Sunday.

U.S., China reaffirm commitment to Phase 1 trade deal in phone call

Aug 25 2020

WASHINGTON/BEIJING Top U.S. and Chinese trade officials reaffirmed their commitment to a Phase 1 trade deal, which has seen China lagging on its obligations to buy American goods, giving a boost to financial markets on Tuesday.

Testing of CanSino's COVID-19 candidate vaccine begins in Russia

Aug 17 2020

MOSCOW/BEIJING Russia's Petrovax has started a late-stage trial of a COVID-19 candidate vaccine from CanSino Biologics Inc in the country, records show, as the Chinese drug firm steps up testing abroad to close in on regulatory approval.

Chinese cities find coronavirus in frozen food imports, WHO downplays infection risk

Aug 13 2020

BEIJING/SHANGHAI/BRASILIA Two cities in China have found traces of the new coronavirus in cargoes of imported frozen food, local authorities said on Thursday, although the World Health Organization downplayed the risk of the virus entering the food chain.

Sinovac launches Phase 3 trial for COVID-19 vaccine in Indonesia, reports Phase 2 details

Aug 11 2020

JAKARTA/BEIJING China's Sinovac Biotech Ltd launched a late-stage human trial on Tuesday that will involve as many as 1,620 patients in Indonesia for a COVID-19 vaccine candidate that it is developing with Indonesian state-owned peer Bio Farma.

World News